Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dog study reveals information about human brain tumours
Boxer
Brachycephalic breeds like boxers and bulldogs are at particular risk of developing glioma.

Genome responsible for rare Glioma discovered

Researchers have located genomes in a study into closely linked dog and human brain tumours.

Published in the journal PLOS Genetics,  scientists from Uppsala University and Swedish University of Agricultural Sciences, analysed genes in different dog breeds linked to the development of the rarely curable glioma.

Brachycephalic breeds like boxers and bulldogs are at particular risk of developing glioma. By
identifying a genomic region shared by the breeds, researchers determined that genomic links were likely.

"In our study we hypothesized that since the brachycephalic dog breeds with elevated risk are closely related we would be able to identify a genomic region shared by those breeds," says Katarina Truvé, former doctoral student at the Swedish University of Agricultural Sciences.

She contiued: "The same risk factors for glioma could also be present in other breeds and the way to identify the genomic region would be to compare genetic markers from dogs diagnosed with glioma from several breeds to healthy controls."

Further genetic analyses were performed using 25 different dog breeds and the researchers could identify an area in the genome that differed between diseased and healthy dogs.

Within this genome, three genes were identified as associated with glioma development, which humans also have.  

Karin Forsberg Nilsson, Professor at the Department of Immunology, Genetics and Pathology and Science for Life Laboratory, said: "These results indicate that further investigations of the role of these three genes in glioma development would be of interest, with potential benefit to both dog and human."

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
Bluetongue RZ extended across Scotland

The Scottish Government has announced an extension to a Bluetongue Restricted Zone that is in place in south-west Scotland.

From 3 October, the Restricted Zone will be extended to cover the whole of Scotland. The Animal, Plant and Health Agency (APHA) says this is in response to further disease spread, as well as simplify trading conditions ahead of the autumn.

Since the whole country will share a disease status, it will no longer be necessary to have a movement license to move susceptible livestock around the country. Restrictions on germinal products remain.

As of 1 October 2026, there were 1,979 cases of BTV-3 in England, 389 cases in Wales and 40 cases in Scotland.